Antimalarial agents
US12350270B2 · kind B2 · utility
0Cited by
0References
52Claims
0Family size
Assignees
Inventors
Key dates
| Filing date | Jul 21, 2020 |
| Grant date | Jul 8, 2025 |
| Priority date | — |
| Expiry date | Jul 25, 2042 |
Classification
- Technology area (CPC Y)Emerging Cross-Sectional Technologies
- CPC primaryY02A50/30
- WIPO fieldPharmaceuticals
- WIPO sectorChemistry
Abstract
Methods of treating malaria comprising administration of compounds of Formula (I′) or a pharmaceutically acceptable salt thereof, to a subject in need thereof, wherein the variables are as defined herein. It also provides uses of the compounds of Formula (I), as defined herein, for inhibiting plasmepsin X, plasmepsin IX or plasmepsin X and IX activity, for treating a Plasmodium infection, and for treating malaria. Also provided are methods of treatment further comprising administration of one or more additional anti-malarial compounds.
Source: USPTO / EPO open patent data. Objective bibliographic and citation counts.